AR
ARTV
Artiva Biotherapeutics, Inc.
4.19
+0.00%
2026-11-02
Last 90d 6 insider sales
52-week range
2.96
14.53
1-month-38.7%
3-month-62.1%
1-year+6.3%
vs 50-day-47.5%
vs 200-day-47.8%
Volatility139%
Beta1.75
$ vol/day$6M
ATH17.31
From ATH-75.8%
Next report2026-11-12
Nothing written about ARTV yet.
Be the first — call it long or short with an entry we price for you,
or post a neutral write-up that takes no side.
Create a free account
2026AprJulOct
bought sold · bigger dot, bigger trade · follows the chart’s range
| When | People | Size | Value | Price | |
|---|---|---|---|---|---|
| 27d | sched | 1 | $168,880 | 7.05 | |
| 28d | sell | 4 | $557,266 | 7.15 | |
| 2mo | sched | 1 | $255,746 | 10.94 | |
| 2mo | sell | 4 | $911,906 | 11.14 | |
| 2mo | sched | 1 | $98,736 | 11.12 | |
| 2mo | sched | 1 | $5,148 | 11.53 | |
| 3mo | buy | 1 | $455,726 | 10.04 | |
| 3mo | buy | 1 | $412,777 | 10.30 | |
| 3mo | buy | 1 | $2,641,621 | 9.77 | |
| 3mo | buy | 1 | $1,432,119 | 9.57 | |
| 4mo | buy | 1 | $194,040 | 9.22 | |
| 4mo | buy | 1 | $292,126 | 9.71 | |
| 5mo | buy | 1 | $4,599,903 | 8.88 | |
| 5mo | buy | 1 | $7,650,148 | 7.64 | |
| 5mo | buy | 1 | $16,499,992 | 7.62 | |
| 6mo | sell | 5 | $477,890 | 8.84 | |
| 6mo | buy | 1 | $99,999,982 | 10.58 | |
| 11mo | sched | 1 | $19,122 | 5.67 | |
| 12mo | sched | 1 | $21,548 | 3.37 | |
| 1.0y | sched | 1 | $153,000 | 6.25 | |
| 1.2y | sched | 1 | $69,615 | 2.98 | |
| 2.3y | buy | 2 | $109,999,992 | 12.34 | |
| 2.3y | buy | 3 | $54,999,960 | 11.98 |
Next report 2026-11-12 (Thursday, after close, in 9 days) · EPS estimate -0.53. It has finished the next session higher 44% of the time, average move 8.5%.
Day-after move, last 9 reports, oldest left.
| Reported | Est. | Actual | Surprise | Gap | Day 1 | Day 5 | |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | beat | -0.64 | -0.63 | +1.9% | +0.4% | -2.7% | -1.1% |
| 2026-05-08 | miss | -0.84 | -0.95 | -12.7% | -3.8% | -13.0% | -21.9% |
| 2026-03-10 | miss | -0.80 | -0.84 | -5.0% | +0.7% | +17.3% | -4.6% |
| 2025-11-12 | miss | -0.80 | -0.88 | -10.0% | +0.0% | +10.9% | -5.6% |
| 2025-08-07 | -0.77 | — | — | -2.8% | -8.0% | -5.9% | |
| 2025-08-06 | miss | -0.77 | -0.87 | -13.0% | -2.8% | -8.0% | -5.9% |
| 2025-05-08 | miss | -0.62 | -0.83 | -33.9% | +3.3% | +3.8% | +1.4% |
| 2024-11-12 | miss | -0.63 | -0.87 | -37.5% | +1.5% | -10.5% | -16.1% |
| 2024-08-29 | beat | -1.59 | -0.64 | +59.9% | -3.9% | +2.1% | +6.2% |
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.1%
Next 1 week
-3.5%
Next 1 month
+4.1%
Mean reversion
Deeply oversold — RSI(2) at 2
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is -0.61%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.75 +4.1%
$6M/day volume
139% volatility
+6% 1-year
-76% from ATH
52-week range · 11% of the way up · -71% from the high
$2.96$14.53
Not investment advice.
Continue with Google